mdl 1

(Z)-MDL 105519是 MDL105519 无活性的异构体。

MDL 100009 是 MDL 100151 的 S-对映体和 MDL 100907 的相反对映体，是 5-HT2A 的选择性拮抗剂。

MDL 19301 is a nonsteroidal, anti-inflammatory agent.

MDL 105519 is an effective antagonist of glycine binding to the NMDA receptor.

MDL 101146 is an orally active neutrophil elastase inhibitor.

MDL 100748 is a glycine site antagonist of NMDA receptor.

Fexofenadine (Carboxyterfenadine) 是一种抗组胺药物，用于治疗过敏症状，如鼻塞、花粉热和荨麻疹。与第一代抗组胺药相比，它通过血脑屏障并引起镇静的能力较差。

meta-Fexofenadine (meta-MDL-16455) 是 Fexofenadine 的异构体。

Volinanserin (MDL100907) 是选择性的5-HT2受体拮抗剂，Ki 值为 0.36 nM，可用于精神疾病的研究。它对 5-HT2 受体的选择性比 5-HT1c、α-1 肾上腺素能受体和 σ 受体高 300 倍。

MDL-19744A is an alpha 1-adrenergic receptor antagonist and renal vasodilator.

MDL-105212A HCl is a nonpeptide NK-1 and NK-2 receptor antagonist.

Fexofenadine-d6 (MDL-16455-d6) 是 Fexofenadine 的氘代物，可用做检测人血浆中非索非那定浓度的内标。

Glemanserin (MDL11939) 是一种特异性 5-HT2A 拮抗剂，对兔、人和大鼠 5-HT2A 的 Ki 值为 0.54 nM、2.5 nM 和 2.89 nM。

MDL-101146, (R)- is an effective orally active inhibitor of human neutrophil elastase.

MDL-101146, (S)- is an effective orally active inhibitor of human neutrophil elastase.

Flavopiridol hydrochloride (MDL 107826A) 是一种CDK 的广谱抑制剂，与 ATP 竞争性地抑制 CDK1，CDK2 和 CDK4 的活性，IC50值分别为 30, 170, 100 nM。

MDL-100240 is a dual inhibitor of angiotensin-converting enzyme (ACE) and neprilysin with a balanced activity. MDL 100240 shows an impressive effectiveness both in preventing and in regressing hypertension-induced vascular remodeling and cardiac hypertrop

TOFA (MDL14514) 是有效的乙酰辅酶 A 羧化酶-α (ACCA)的变构抑制剂。

Piroximone is a phosphodiesterase (PDE) inhibitor.

Enoximone sulfoxide is a selective phosphodiesterase III (PDE3) inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. Enoximone prevents the degradation of cAMP by PDE, which prolongs signal transduction and its subsequent effects. It is used in patients with congestive heart failure.

RMI-12330A is an adenyl cyclase inhibitor.

Plomestane is a selective inhibitor of aromatization in human breast tissue and may provide a mechanism for controlling estrogen responsive processes.

RMI-18341 is a Testosterone 5 alpha reductase inhibitor.

Premazepam is a benzodiazepine derivative. It is a partial agonist of benzodiazepine receptors and was shown in 1984 to possess both anxiolytic and sedative properties in humans but was never marketed.